Nan Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nan Xu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Hengyuan Gao
Department of General Surgery, the First Affiliated Hospital of Jinan University; Department of Physiology, School of Medicine, Jinan University, Guangzhou, China
1 shared publication- Junchang Zhang
Division of Thyroid Surgery, Department of General Surgery, Department of General Practice, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China
1 shared publication Junqing Lin
Division of Thyroid Surgery, Department of General Surgery, Department of General Practice, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China
1 shared publicationXiaobing Chen
Division of Thyroid Surgery, Department of General Surgery, Department of General Practice, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China
1 shared publication- Xiaoyong Dai
Precision Medicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China
1 shared publication Yibin Huang
Synorg Biotechnology (Shenzhen) Co. Ltd., Shenzhen, China
1 shared publication
Latest Publications
- Open Access
- 27 February 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Microfluidic-based patient-derived organoids recapitulate thyroid cancer heterogeneity and reveal NF-κB-driven maturation for precision therapy
Inter-tumor heterogeneity poses significant challenges for precision therapy in thyroid cancer (TC). The conventional organoid models are limited by ineffi
- 27 February 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessMicrofluidic-based patient-derived organoids recapitulate thyroid cancer heterogeneity and reveal NF-κB-driven maturation for precision therapy
Inter-tumor heterogeneity poses significant challenges for precision therapy in thyroid cancer (TC). The conventional organoid models are limited by ineffi